Surrozen Inc. (SRZNW)
0.03
-0.00 (-1.96%)
At close: Mar 03, 2025, 9:32 AM
No 1D chart data available
| Bid | 0.02 |
| Market Cap | 37.26M |
| Revenue (ttm) | 5.15B |
| Net Income (ttm) | -16.17B |
| EPS (ttm) | -5.695 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.04 |
| Volume | 600 |
| Avg. Volume (20D) | 19,181.068 |
| Open | 0.03 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Beta | 0.74 |
About SRZNW
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its pro...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 10, 2021
Employees 42
Stock Exchange NASDAQ
Ticker Symbol SRZNW
Website http://www.surrozen.com